We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience.
- Authors
Nichols, Craig R.; Saxman, Scott; Williams, Stephen D.; Loehrer, Patrick J.; Miller, Michael E.; Wright, Cameron; Einhorn, Lawrence H.; Nichols, C R; Saxman, S; Williams, S D; Loehrer, P J; Miller, M E; Wright, C; Einhorn, L H
- Abstract
Between 1976 and 1988, 31 patients with mediastinal nonseminomatous germ cell tumors (MNGCT) received initial cisplatin-based chemotherapy of uniform intensity. Eighteen of these patients (58%) obtained disease-free status; 11 with chemotherapy alone and seven with adjunctive surgery. Eleven have remained continuously free of disease. Two have had recurrence of teratoma and are disease-free after resection of teratoma at 12+ and 68+ months. Three patients developed recurrence of germ cell tumor. Three patients developed a hematologic malignancy. Of the 18 patients who obtained disease-free status, 15 remain alive and disease-free. Overall, 13 of the 31 patients and 24 other patients received salvage chemotherapy at Indiana University, Indianapolis, Indiana. Of these 37 patients, six obtained a disease-free status and four (11%) remain alive at 13+, 56+, 78+, and 122+ months, respectively. This series represents the largest series of patients with MNGCT ever reported. Analysis of these data and results from other recent series suggest that approximately 50% of patients with MNGCT will be cured with modern, intense cisplatin-based chemotherapy coupled with adjunctive surgery if needed.
- Publication
Cancer (0008543X), 1990, Vol 65, Issue 7, p1641
- ISSN
0008-543X
- Publication type
journal article
- DOI
10.1002/1097-0142(19900401)65:7<1641::AID-CNCR2820650731>3.0.CO;2-U